News Focus
News Focus
icon url

DewDiligence

10/21/20 2:34 PM

#235223 RE: DewDiligence #235218

ABT sold $880M of COVID-19 diagnostics in 3Q20! The 4Q20 figure is expected to be >=$1.3B.
icon url

DewDiligence

01/27/21 8:41 AM

#236848 RE: DewDiligence #235218

ABT sold $2.4B of COVID-19 diagnostics during 4Q20!

https://abbott.mediaroom.com/2021-01-27-Abbott-Reports-Fourth-Quarter-2020-Results-Issues-Strong-Double-Digit-Growth-Forecast-for-2021

Non-GAAP EPS guidance for 2021 is >=$5.00, +37% (or more) relative to 2020’s $3.65.